Human Xt-M (HUMX.M) AI Stock Analysis

• Market Cap: ₪4.92M
• Dividend Yield: N/A
• Average Volume (3M): 50.09K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.18
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IL
• Employees: 21
• Sector: Technology
• Sector Strength: 88
• Industry: Medical - Devices
• EPS (TTM): N/A
• Shares Outstanding: 26,756,048
• 10 Day Avg. Volume: 22,744
• 30 Day Avg. Volume: 50,094
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: 23.00 ▼(-10.85% Downside)
• Action: Upgraded Date: 01/28/26
• Date: Action: Upgraded 01/28/26

The score is held down primarily by weak financial performance, including a major 2024 revenue decline, negative gross profit, large losses, and persistent cash burn despite low debt. Technicals offer only modest support via short-term strength, while valuation is constrained by a loss-making profile (negative P/E) and no dividend yield support.

Positive Factors

Very low leverage

Zero reported debt materially reduces refinancing and interest-rate risk and preserves financial optionality. Over a 2–6 month horizon this strengthens the firm's ability to negotiate restructuring, access capital markets if needed, and prioritize operational fixes without immediate debt-service pressure.

Negative Factors

Sharp 2024 revenue collapse and negative gross profit

A ~74% revenue drop paired with negative gross profit indicates unit economics are broken and costs exceed sales. Structurally, this undermines margin sustainability and means simple volume recovery alone won’t restore profitability; durable remediation requires major cost or business-model changes.

Human Xt-M Business Overview & Revenue Model

Company Description

Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monop...

Read more

Human Xtensions Ltd. develops, manufactures, markets and sells a modular medical device for minimally invasive surgical operations. It offers HandX, a handheld electromechanical device for use in laparoscopic procedures; Fenestrated Grasper; Monop...

How the Company Makes Money

Human Xt (HUMX) generates revenue through the sale of its smart wearable devices and augmented reality applications, which are available to both individual consumers and corporate clients. The company also offers AI-driven software solutions on a ...

Read more

Human Xt (HUMX) generates revenue through the sale of its smart wearable devices and augmented reality applications, which are available to both individual consumers and corporate clients. The company also offers AI-driven software solutions on a ...

Human Xt-M Financial Statement Overview

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Human Xt-M Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 25.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HUMX.M, the sentiment is Negative. The current price of 25.8 is above the 20-day moving average (MA) of 18.34, above the 50-day MA of 19.92, and above the 200-day MA of 24.21, indicating a neutral trend. The MACD of -0.65 indicates Positive momentum. The RSI at 44.98 is Neutral, neither overbought nor oversold. The STOCH value of 89.81 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HUMX.M.

Human Xt-M Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
HUMX.M	46 Neutral	₪4.92M	-3.87	―	―	―	―